Tennessee Department of Health Confirms Two Additional Measles Cases
On Apr. 17, 2025, The Tennessee Department of Health confirmed two additional confirmed cases of measles in middle…
Tennessee Department of Health Confirms Three Additional Measles Cases
On Apr. 1, 2025, the Tennessee Department of Health confirmed three additional cases of measles in Middle Tennessee…
Tennessee Department of Health Confirmed 1st Measles Case in the State
On Mar. 21 , 2025, the Tennessee Department of Health confirmed the state’s first measles case in 2025…
St, Judes Reports Promising results from first prenatal therapy for spinal muscular atrophy
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
RSV vaccine in older people reduced risk of hospitalization
On Sep. 4, 2024, researcher led by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University…
New initiative aimed to sequence half a million genomes of people with African ancestry for health studies
On Oct. 18, 2023, an industry-academic initiative was announced that aimed to create the largest ever database of…
U.S. FDA Approved First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for the Treatment of Cervical Dystonia
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
FDA Approved Daxxify, a New Anti-Wrinkle Drug
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
Mandatory masking in schools reduced COVID-19 cases during Delta surge
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
ADMA Biologics received FDA approval for plasma collection facility in Maryville, TN
On Aug. 16, 2021, ADMA Biologics announced that it had received U.S. Food and Drug Administration approval for…
Fostamatinib selected for NIH ACTIV-4 COVID-19 clinical trial
On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…
CHF Solutions announced deployment of Aquadex Systems to hospitals in the s to treat COVID-19 patients
On Oct. 27, 2020, CHF Solutions announced that it had shipped Aquadexﾙ product to medical facilities in Tennessee…
Aegis Sciences doubled capacity for Coronavirus disease 2019 (COVID-19) testing
On Apr. 27, 2020, Aegis Sciences announced expanded capacity to incrementally ramp up to 7,000 tests per day…
Aegis Sciences launched test for Coronavirus disease 2019 (COVID-19)
On Apr. 13, 2020, Aegis Sciences announced serving as a regional reference laboratory for COVID-19 testing being directed…
NIH began clinical trial of hydroxychloroquine as potential therapy for COVID-19
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…
Vanderbilt University Medical Center researchers announced new insight on diabetic retinopathy
On Jan. 23, 2020, Vanderbilt University Medical Center researchers Megan Capozzi, PhD, John Penn, PhD, and colleagues showed…
The Vanderbilt Vaccine Research Program received NIH grant to continue work as Vaccine and Treatment Evaluation
On Jan. 23, 2020, the Vanderbilt Vaccine Research Program (VVRP) received a grant from the National Institutes of…
Vanderbilt University Medical Center professor Ege T Kavalali, Ph.D. received a Humboldt Research Award
On Dec. 31, 2019, Ege T. Kavalali, Ph.D., professor and acting chair of the Department of Pharmacology in…
Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
The University of Tennessee Institute of Agriculture was awarded a grant to study cattle genomics
On Dec. 2, 2019, the University of Tennessee Institute of Agriculture announced it had received a grant by…
FDA approved new sickle cell treatment based on clincal trial resutls from UTHSC’s Kenneth Ataga, MD
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
Vanderbilt-Ingram Cancer Center (VICC) announced new role in international cancer database project, Project GENIE
On Nov. 7, 2019, the Vanderbilt-Ingram Cancer Center (VICC) announced its new role in the Project GENIE (Genomics…
UT Professor Elizabeth Derryberry was recognized as an important female ornithologist by the Cornell Lab of Ornithology
On Oct. 21, 2019, Elizabeth Derryberry, professor of ecology and evolutionary biology at the University of Tennessee (UT),…
Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
St Jude and World Health Organization announce a five-year collaboration to transform cancer care
On Sept. 27, 2018, St.ﾠJude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
PMI BioPharma Solutions was founded
In 2018, PMI BioPharma Solutions was established in Nashville to offer a full range of research and development…
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
New prostate cancer therapy investigated at Vanderbilt University Medical Center
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…